Day One (13th May 2025)Tuesday, 13 May 2025 - CET/CEST (Cent Europe Summer, GMT+2)

Current cell therapy manufacturing sciences are evolving rapidly to enable more reliable and faster scale-up and scale-out of lab-based processes to GMP manufacturing. The key challenge is striking a balance between significantly reducing time-to-market and integrating as many commercialization solutions as possible into the process. In this review, we share key lessons learned from recent engineering and GMP runs, highlighting the impact of automation and process modeling in enhancing readiness for final product supply.